**Exhibit
        31**
 
 **Certifications**
 
 I,
        Dr.
        Ramesh Zacharias, certify that:
 
 1.
        I
        have reviewed this quarterly report on Form 10-Q of Med-Emerg International
        Inc.;
 
 2.
        Based on my knowledge, this quarterly report does not contain any untrue
        statement of a material fact or omit to state a material fact necessary to
        make
        the statements made, in light of the circumstances under which such statements
        were made, not misleading with respect to the period covered by this quarterly
        report;
 
 3.
        Based on my knowledge, the financial statements, and other financial information
        included in this quarterly report, fairly present in all material respects
        the
        financial condition, results of operations and cash flows of the registrant
        as
        of, and for, the periods presented in this quarterly report;
 
 4.
        The
        registrant's other certifying officers and I are responsible for establishing
        and maintaining disclosure controls and procedures (as defined in Exchange
        Act
        Rules 13a-14 and 15d-14) for the registrant and we have:
 
 a)
        designed such disclosure controls and procedures to ensure that material
        information relating to the registrant, including its consolidated subsidiaries,
        is made known to us by others within those entities, particularly during
        the
        period in which this quarterly report is being prepared;
 
 b)
        evaluated the effectiveness of the registrant's disclosure controls and
        procedures and presented in this report our conclusions about the effectiveness
        of the disclosure controls and procedures, as of the end of the period covered
        by this report based on such evaluation; and
 
 c)
        disclosed in this quarterly report any change in the registrant’s internal
        control over financial reporting that occurred during the registrant’s third
        fiscal quarter that has materially affected, or is reasonably likely to
        materially affect, the registrant’s internal control over financial
        reporting.
 
 5.
        The
        registrant's other certifying officers and I have disclosed, based on our
        most
        recent evaluation of internal control over financial reporting, to the
        registrant's auditors and the audit committee of registrant's board of directors
        (or persons performing the equivalent functions):
 
 a)
        all
        significant deficiencies and material weaknesses in the design or operation
        of
        internal control over financial reporting which are reasonably likely to
        adversely affect the registrant’s ability to record, process, summarize and
        report financial information; and
 
 b)
        any
        fraud, whether or not material, that involves management or other employees
        who
        have a significant role in the registrant's internal control over financial
        reporting.
  Date: 
        November 30, 2005
  /s/
                  Dr.
                  Ramesh ZachariasDr.
                  Ramesh ZachariasChief
                  Executive Officer
 
 
 
 
  
   I,
        William Danis, certify that:
 
 1.
        I
        have reviewed this quarterly report on Form 10-Q of Med-Emerg International
        Inc.;
 
 2.
        Based on my knowledge, this quarterly report does not contain any untrue
        statement of a material fact or omit to state a material fact necessary to
        make
        the statements made, in light of the circumstances under which such statements
        were made, not misleading with respect to the period covered by this quarterly
        report;
 
 3.
        Based on my knowledge, the financial statements, and other financial information
        included in this quarterly report, fairly present in all material respects
        the
        financial condition, results of operations and cash flows of the registrant
        as
        of, and for, the periods presented in this quarterly report;
 
 4.
        The
        registrant's other certifying officers and I are responsible for establishing
        and maintaining disclosure controls and procedures (as defined in Exchange
        Act
        Rules 13a-14 and 15d-14) for the registrant and we have:
 
 a)
        designed such disclosure controls and procedures to ensure that material
        information relating to the registrant, including its consolidated subsidiaries,
        is made known to us by others within those entities, particularly during
        the
        period in which this quarterly report is being prepared;
 
 b)
        evaluated the effectiveness of the registrant's disclosure controls and
        procedures and presented in this report our conclusions about the effectiveness
        of the disclosure controls and procedures, as of the end of the period covered
        by this report based on such evaluation; and
 
 c)
        disclosed in this quarterly report any change in the registrant’s internal
        control over financial reporting that occurred during the registrant’s third
        fiscal quarter that has materially affected, or is reasonably likely to
        materially affect, the registrant’s internal control over financial
        reporting.
 
 5.
        The
        registrant's other certifying officers and I have disclosed, based on our
        most
        recent evaluation of internal control over financial reporting, to the
        registrant's auditors and the audit committee of registrant's board of directors
        (or persons performing the equivalent functions):
 
 a)
        all
        significant deficiencies and material weaknesses in the design or operation
        of
        internal control over financial reporting which are reasonably likely to
        adversely affect the registrant’s ability to record, process, summarize and
        report financial information; and
 
 b)
        any
        fraud, whether or not material, that involves management or other employees
        who
        have a significant role in the registrant's internal control over financial
        reporting.
 
 Date: 
        November 30, 2005
  /s/
                  William
                  DanisWilliam
                  DanisChief
                  Financial Officer